Physiotherapy Equipment Market by Product (Equipment (Electrotherapy, Ultrasound, Cryotherapy, Laser Therapy), Accessories), Application (Musculoskeletal and Orthopedic, Neurological, Sports Rehabilitation), End User and Region - Global Forecast to 2031
The global physiotherapy equipment market size is projected to reach USD 8.37 billion by 2031 from USD 6.11 billion in 2026, at a CAGR of 6.5% during the forecast period.
Lifestyle factors, such as lack of exercise and poor dieting, compounded by an aging population, explain the growth of chronic illnesses like arthritis and cardiovascular diseases. The rehabilitation requirements increase correspondingly. Concomitantly, the increased number of rehabilitation requirements leads to an upsurge in demand for physiotherapy equipment for managing older people's mobility and pain relief. The market is also driven by several other factors, such as technological advancements, rising R&D spending, increased awareness, the need for personalized physiotherapy equipment, and economic expansion in emerging countries.
“The electrotherapy segment is expected to dominate the market.”
Electrotherapy is one of the most widely adopted modalities in physiotherapy for pain management, muscle rehabilitation, and functional recovery across musculoskeletal and neurological conditions. Common electrotherapy techniques include Transcutaneous Electrical Nerve Stimulation (TENS), Interferential Therapy (IFT), Electrical Muscle Stimulation (EMS), Percutaneous Electrical Nerve Stimulation (PENS), and Therapeutic Ultrasound. These modalities provide non-invasive treatment options that help relieve acute and chronic pain, accelerate the healing of musculoskeletal injuries, improve blood circulation, promote wound healing, reduce inflammation, and relax muscle spasms, with minimal side effects. Technological advancements have further enhanced treatment efficacy through the development of compact, portable, and digitally connected electrotherapy devices, enabling both clinical and home-based rehabilitation. Furthermore, the growing availability of programmable treatment protocols and personalized therapy settings has improved patient adherence, convenience, and overall rehabilitation outcomes, supporting the increasing adoption of electrotherapy equipment across healthcare settings.
“Musculoskeletal & orthopedic rehabilitation segment accounted for the largest share of the applications market in 2025.”
Musculoskeletal and orthopedic rehabilitation plays a vital role in the treatment and recovery of conditions such as ligament sprains, muscle strains, osteoarthritis, fractures, spinal disorders, cartilage injuries, joint replacements, and other pre- and post-operative orthopedic conditions. The increasing burden of musculoskeletal and orthopedic disorders is driven by a rapidly aging population, rising participation in sports and recreational activities, sedentary lifestyles, increasing obesity rates, and repetitive occupational strain. Furthermore, the growing incidence of road traffic accidents, workplace injuries, and trauma-related musculoskeletal conditions has accelerated the demand for rehabilitation services. As healthcare providers increasingly emphasize early intervention, functional recovery, and improved mobility, the adoption of advanced physiotherapy equipment across hospitals, rehabilitation centers, outpatient clinics, and home care settings continues to expand, supporting enhanced clinical outcomes and reducing long-term disability.
“The Asia Pacific is estimated to register the highest CAGR during the forecast period.”
The physiotherapy equipment market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. The Asia Pacific is projected to register the highest CAGR during the forecast period. The region's growth is primarily driven by its rapidly aging population, increasing incidence of musculoskeletal disorders, stroke, and sports injuries, and rising awareness regarding early rehabilitation and physiotherapy. In addition, expanding healthcare infrastructure, increasing healthcare expenditure, improving access to rehabilitation services, and favorable government initiatives in countries such as China, India, Japan, South Korea, and Australia are accelerating the adoption of advanced physiotherapy equipment. The growing number of rehabilitation centers, coupled with increasing investments by both public and private healthcare providers, is expected to further drive market growth across the region.
The break-up of the profile of primary participants in the physiotherapy equipment market:
Research Coverage
This report examines the physiotherapy equipment market by product, application, end-user, and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the market opportunities and challenges for stakeholders and provides details on the competitive landscape for market leaders. The report also examines micro-markets in terms of their growth trends, prospects, and contributions to the total physiotherapy equipment market. The report forecasts revenue for the market segments across five major regions.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall physiotherapy equipment market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Lifestyle factors, such as lack of exercise and poor dieting, compounded by an aging population, explain the growth of chronic illnesses like arthritis and cardiovascular diseases. The rehabilitation requirements increase correspondingly. Concomitantly, the increased number of rehabilitation requirements leads to an upsurge in demand for physiotherapy equipment for managing older people's mobility and pain relief. The market is also driven by several other factors, such as technological advancements, rising R&D spending, increased awareness, the need for personalized physiotherapy equipment, and economic expansion in emerging countries.
“The electrotherapy segment is expected to dominate the market.”
Electrotherapy is one of the most widely adopted modalities in physiotherapy for pain management, muscle rehabilitation, and functional recovery across musculoskeletal and neurological conditions. Common electrotherapy techniques include Transcutaneous Electrical Nerve Stimulation (TENS), Interferential Therapy (IFT), Electrical Muscle Stimulation (EMS), Percutaneous Electrical Nerve Stimulation (PENS), and Therapeutic Ultrasound. These modalities provide non-invasive treatment options that help relieve acute and chronic pain, accelerate the healing of musculoskeletal injuries, improve blood circulation, promote wound healing, reduce inflammation, and relax muscle spasms, with minimal side effects. Technological advancements have further enhanced treatment efficacy through the development of compact, portable, and digitally connected electrotherapy devices, enabling both clinical and home-based rehabilitation. Furthermore, the growing availability of programmable treatment protocols and personalized therapy settings has improved patient adherence, convenience, and overall rehabilitation outcomes, supporting the increasing adoption of electrotherapy equipment across healthcare settings.
“Musculoskeletal & orthopedic rehabilitation segment accounted for the largest share of the applications market in 2025.”
Musculoskeletal and orthopedic rehabilitation plays a vital role in the treatment and recovery of conditions such as ligament sprains, muscle strains, osteoarthritis, fractures, spinal disorders, cartilage injuries, joint replacements, and other pre- and post-operative orthopedic conditions. The increasing burden of musculoskeletal and orthopedic disorders is driven by a rapidly aging population, rising participation in sports and recreational activities, sedentary lifestyles, increasing obesity rates, and repetitive occupational strain. Furthermore, the growing incidence of road traffic accidents, workplace injuries, and trauma-related musculoskeletal conditions has accelerated the demand for rehabilitation services. As healthcare providers increasingly emphasize early intervention, functional recovery, and improved mobility, the adoption of advanced physiotherapy equipment across hospitals, rehabilitation centers, outpatient clinics, and home care settings continues to expand, supporting enhanced clinical outcomes and reducing long-term disability.
“The Asia Pacific is estimated to register the highest CAGR during the forecast period.”
The physiotherapy equipment market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. The Asia Pacific is projected to register the highest CAGR during the forecast period. The region's growth is primarily driven by its rapidly aging population, increasing incidence of musculoskeletal disorders, stroke, and sports injuries, and rising awareness regarding early rehabilitation and physiotherapy. In addition, expanding healthcare infrastructure, increasing healthcare expenditure, improving access to rehabilitation services, and favorable government initiatives in countries such as China, India, Japan, South Korea, and Australia are accelerating the adoption of advanced physiotherapy equipment. The growing number of rehabilitation centers, coupled with increasing investments by both public and private healthcare providers, is expected to further drive market growth across the region.
The break-up of the profile of primary participants in the physiotherapy equipment market:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4%
Research Coverage
This report examines the physiotherapy equipment market by product, application, end-user, and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the market opportunities and challenges for stakeholders and provides details on the competitive landscape for market leaders. The report also examines micro-markets in terms of their growth trends, prospects, and contributions to the total physiotherapy equipment market. The report forecasts revenue for the market segments across five major regions.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall physiotherapy equipment market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
- Analysis of key drivers (rapid aging, technological advancements), restraints (unstable reimbursement scenario), challenges (alternate therapies), and opportunities (rise in home healthcare services)
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the physiotherapy equipment Market.
- Market Development: Comprehensive information on the lucrative emerging markets by products, applications, end users, and region.
- Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the physiotherapy equipment market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global physiotherapy equipment market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 OPPORTUNITIES FOR PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
3.2 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET,
BY END USER AND COUNTRY (2025)
3.3 PHYSIOTHERAPY EQUIPMENT MARKET: KEY COUNTRIES
3.4 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION (2026?2031)
3.5 PHYSIOTHERAPY EQUIPMENT MARKET: DEVELOPED VS. EMERGING MARKETS
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rapidly growing geriatric population and increasing incidence of chronic diseases
4.2.1.2 Growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular diseases
4.2.1.3 Rising demand for rehabilitation care
4.2.1.4 Growing demand for home-based and telerehabilitation care
4.2.2 RESTRAINTS
4.2.2.1 Unstable reimbursement scenario for physiotherapy
4.2.2.2 Direct access to physiotherapy
4.2.3 OPPORTUNITIES
4.2.3.1 Emerging markets
4.2.3.2 Rising technological advancements
4.2.4 CHALLENGES
4.2.4.1 Shortage of skilled personnel
4.2.4.2 Alternate therapies such as acupuncture
4.3 UNMET NEEDS & WHITE SPACES
4.3.1 UNMET NEEDS IN PHYSIOTHERAPY EQUIPMENT MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN REHABILITATION EQUIPMENT INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 ROLE IN ECOSYSTEM
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT,
BY PRODUCT, 2025
5.6.2 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT,
BY REGION, 2023–2025
5.7 TRADE ANALYSIS
5.7.1 IMPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019),
2021–2025
5.7.2 EXPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019),
2021–2025
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 CASE STUDY ANALYSIS
5.10.1 CASE STUDY 1: STARTOON LABS RECEIVED USFDA APPROVAL FOR PHEEZEE PHYSIOTHERAPY DEVICE
5.10.2 CASE STUDY 2: NHS IN THE UK TO LAUNCH AI-DRIVEN PHYSIOTHERAPY CLINIC
5.10.3 CASE STUDY 3: BURJEEL AND LEEJAM LAUNCH PHYSIOTHERABIA CENTERS IN RIYADH
5.11 INVESTMENT & FUNDING SCENARIO
5.12 IMPACT OF 2025 US TARIFFS ON PHYSIOTHERAPY EQUIPMENT MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON REGION
5.12.4.1 US
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.5 IMPACT ON END-USE INDUSTRIES
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS,
AND INNOVATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 AUGMENTED REALITY (AR)
6.3 TECHNOLOGY/PRODUCT ROADMAP
6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION
6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.4 PATENT ANALYSIS
6.4.1 PATENT PUBLICATION TRENDS FOR PHYSIOTHERAPY EQUIPMENT MARKET
6.4.2 TOP APPLICANTS (COMPANIES) OF PHYSIOTHERAPY EQUIPMENT PATENTS
6.4.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN PHYSIOTHERAPY EQUIPMENT MARKET
6.4.4 LIST OF MAJOR PATENTS
6.5 IMPACT OF AI/GEN AI ON PHYSIOTHERAPY EQUIPMENT MARKET
6.5.1 TOP USE CASES & MARKET POTENTIAL
6.5.2 TOP CASE STUDIES OF AI IMPLEMENTATION IN PHYSIOTHERAPY EQUIPMENT MARKET
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHYSIOTHERAPY EQUIPMENT MARKET
6.6 SUCCESS STORIES & REAL-WORLD APPLICATIONS
6.6.1 DIH MEDICAL/HOCOMA: LOKOMAT (ROBOT-ASSISTED GAIT REHABILITATION)
6.6.2 BTL INDUSTRIES: EMSELLA (NON-INVASIVE PELVIC FLOOR REHABILITATION)
6.6.3 STORZ MEDICAL: DUOLITH SD1 “ULTRA”(COMBINED SHOCKWAVE THERAPY IN SPORTS REHABILITATION)
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.1.2.1 North America
7.1.2.1.1 US
7.1.2.1.2 Canada
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.3.1 Japan
7.1.2.3.2 China
7.1.2.3.3 India
7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
7.2.1 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PHYSIOTHERAPY EQUIPMENT
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS IN END USERS
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 EQUIPMENT
9.2.1 ELECTROTHERAPY EQUIPMENT
9.2.1.1 Rising demand for non-pharmacological pain-management options to drive market growth
9.2.2 ULTRASOUND EQUIPMENT
9.2.2.1 High prevalence of musculoskeletal disorders and sports injuries and growing postoperative rehabilitation needs to boost growth
9.2.3 EXERCISE THERAPY EQUIPMENT
9.2.3.1 Shift toward active, function-oriented rehabilitation and growing emphasis on measurable clinical outcomes to fuel market growth
9.2.4 HEAT THERAPY EQUIPMENT
9.2.4.1 Expansion of outpatient rehabilitation and availability of portable products for supervised home use to drive growth
9.2.5 CRYOTHERAPY EQUIPMENT
9.2.5.1 Increasing orthopedic procedure volumes to support market growth
9.2.6 COMBINATION THERAPY EQUIPMENT
9.2.6.1 Ability of combination systems to consolidate capital purchases and improve clinical workflow to drive demand
9.2.7 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT
9.2.7.1 Ability to maintain passive joint mobility and reduce adverse effects of prolonged immobilization to fuel market
9.2.8 SHOCKWAVE THERAPY EQUIPMENT
9.2.8.1 Availability of compact radial systems suitable for physiotherapy and sports medicine clinics to boost demand
9.2.9 LASER THERAPY EQUIPMENT
9.2.9.1 Ability of higher-power systems to treat larger areas within shorter sessions to fuel growth
9.2.10 TRACTION THERAPY EQUIPMENT
9.2.10.1 Availability of programmable clinic-based and portable home-use devices to support growth
9.2.11 MAGNETIC PRESSURE THERAPY EQUIPMENT
9.2.11.1 Introduction of higher-intensity systems capable of stimulating deeper tissues without direct skin contact to drive adoption
9.2.12 OTHER PHYSIOTHERAPY EQUIPMENT
9.3 ACCESSORIES
9.3.1 PHYSIOTHERAPY FURNITURE
9.3.1.1 Growing use for physical therapy, rehab, occupational therapy, sports medicine, and chiropractic medicine to drive market
9.3.2 OTHER ACCESSORIES
10 PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 MUSCULOSKELETAL & ORTHOPEDIC REHABILITATION
10.2.1 RISING INCIDENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE DEMAND
10.3 NEUROLOGICAL REHABILITATION
10.3.1 SIGNIFICANT UNMET REHABILITATION NEEDS, PARTICULARLY IN EMERGING ECONOMIES, TO CREATE LONG-TERM MARKET OPPORTUNITY
10.4 CARDIOVASCULAR & PULMONARY REHABILITATION
10.4.1 GROWING CARDIOVASCULAR AND RESPIRATORY DISEASE BURDEN TO DRIVE DEMAND FOR EXERCISE THERAPY EQUIPMENT
10.5 SPORTS REHABILITATION
10.5.1 DEMAND FOR STRUCTURED REHABILITATION AND OBJECTIVE RETURN-TO-PLAY ASSESSMENTS TO BOOST MARKET
10.6 PELVIC HEALTH & UROGYNECOLOGICAL REHABILITATION
10.6.1 SHIFT TOWARD OUTPATIENT, HOME-BASED, AND REMOTELY MONITORED PELVIC-HEALTH PROGRAMS TO EXPAND ADDRESSABLE EQUIPMENT BASE
10.7 OTHER APPLICATIONS
11 PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER
11.1 INTRODUCTION
11.2 PHYSIOTHERAPY & REHABILITATION CENTERS
11.2.1 RISING INCIDENCE OF SPORTS INJURIES AND DISABILITIES TO DRIVE SEGMENT
11.3 HOSPITALS
11.3.1 GROWING PATIENT VOLUMES AT HOSPITALS TO DRIVE DEMAND
11.4 HOME CARE SETTINGS
11.4.1 RISING DEMAND FOR HOME CARE TO DRIVE DEMAND
11.5 PHYSICIANS’ OFFICES
11.5.1 COST-SAVING POTENTIAL AND QUALITY OF CARE PROVIDED IN PHYSICIANS’ OFFICES TO DRIVE GROWTH
11.6 OTHER END USERS
12 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 US
12.2.2.1 US to dominate North American market during forecast period
12.2.3 CANADA
12.2.3.1 Growing penetration of preventive care services to boost market
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 GERMANY
12.3.2.1 Rising geriatric population and increase in chronic conditions to drive demand
12.3.3 UK
12.3.3.1 Wide acceptance of physical therapy to increase adoption of physiotherapy equipment
12.3.4 FRANCE
12.3.4.1 Rising healthcare expenditure and favorable reimbursement scenario to drive market
12.3.5 ITALY
12.3.5.1 Increasing incidence of fall injuries and orthopedic disorders to drive market
12.3.6 SPAIN
12.3.6.1 Rising geriatric population to drive adoption of physiotherapy equipment
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 JAPAN
12.4.2.1 Large geriatric population to drive adoption of physiotherapy equipment
12.4.3 CHINA
12.4.3.1 Global manufacturing hub for physiotherapy and rehabilitation equipment to drive market
12.4.4 INDIA
12.4.4.1 Expansion of new acute care settings to drive demand
12.4.5 AUSTRALIA
12.4.5.1 Growing population and rising cases of chronic musculoskeletal conditions to drive market
12.4.6 SOUTH KOREA
12.4.6.1 Fast-growing aging population and rising medical tourism to drive market
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Rapidly aging population and expanding healthcare infrastructure to augment market growth
12.5.3 MEXICO
12.5.3.1 Advancements in healthcare infrastructure to drive market
12.5.4 ARGENTINA
12.5.4.1 Advancements in healthcare infrastructure to drive market
12.5.5 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 GCC COUNTRIES
12.6.2.1 Robust healthcare industry to drive market
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
13.3 REVENUE ANALYSIS, 2021–2025
13.4 MARKET RANKING ANALYSIS
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Product footprint
13.5.5.4 Application footprint
13.5.5.5 End-user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1 List of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 BRAND/PRODUCT COMPARISON
13.8 COMPANY VALUATION & FINANCIAL METRICS
13.8.1 FINANCIAL METRICS
13.8.2 COMPANY VALUATION
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & APPROVALS
13.9.2 DEALS
13.9.3 EXPANSIONS
13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION)
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches
14.1.1.3.2 Deals
14.1.1.3.3 Expansions
14.1.1.3.4 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 ZIMMER MEDIZINSYSTEME GMBH
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches
14.1.2.3.2 Deals
14.1.2.3.3 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.)
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches & approvals
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.3.4 Other developments
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS)
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches
14.1.4.3.2 Deals
14.1.4.3.3 Other developments
14.1.4.4 MnM view
14.1.4.4.1 Right to win
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses & competitive threats
14.1.5 ITO CO., LTD.
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 MnM view
14.1.5.3.1 Right to win
14.1.5.3.2 Strategic choices
14.1.5.3.3 Weaknesses & competitive threats
14.1.6 DYNATRONICS CORPORATION
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Product launches
14.1.6.3.2 Deals
14.1.6.3.3 Other developments
14.1.7 BTL INDUSTRIES
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.7.3.2 Deals
14.1.7.3.3 Expansions
14.1.7.3.4 Other developments
14.1.8 ENRAF-NONIUS B.V.
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Deals
14.1.9 MECTRONIC MEDICALE
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.10 RICHMAR (SUBSIDIARY OF DRIVE MEDICAL)
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches
14.1.10.3.2 Deals
14.1.11 STORZ MEDICAL AG
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.11.3 Recent developments
14.1.11.3.1 Product launches
14.1.11.3.2 Deals
14.1.11.3.3 Expansions
14.1.12 GYMNA INTERNATIONAL
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.12.3 Recent developments
14.1.12.3.1 Product launches
14.1.13 ASTAR
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.14 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED)
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 TACTILE MEDICAL
14.1.15.1 Business overview
14.1.15.2 Products offered
14.1.15.3 Recent developments
14.1.15.3.1 Product launches
14.1.16 DIH MEDICAL
14.1.16.1 Business overview
14.1.16.2 Products offered
14.1.16.3 Recent developments
14.1.16.3.1 Product launches
14.1.16.3.2 Deals
14.1.16.3.3 Other developments
14.1.17 TECHNOGYM SPA
14.1.17.1 Business overview
14.1.17.2 Products offered
14.1.17.3 Recent developments
14.1.17.3.1 Expansions
14.1.18 OMRON CORPORATION
14.1.18.1 Business overview
14.1.18.2 Products offered
14.1.19 OG WELLNESS TECHNOLOGIES CO., LTD.
14.1.19.1 Business overview
14.1.19.2 Products offered
14.1.19.3 Recent developments
14.1.19.3.1 Deals
14.1.20 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.
14.1.20.1 Business overview
14.1.20.2 Products offered
14.1.20.3 Recent developments
14.1.20.3.1 Product approvals & launches
14.2 OTHER PLAYERS
14.2.1 KINVENT
14.2.2 EXOATLET
14.2.3 MANAMED
14.2.4 BEABLE HEALTH PVT. LTD.
14.2.5 BALANCE METRIX
15 RESEARCH METHODOLOGY
15.1 RESEARCH APPROACH
15.1.1 SECONDARY DATA
15.1.1.1 Key data from secondary sources
15.1.2 PRIMARY DATA
15.1.2.1 Key data from primary sources
15.1.2.2 Key industry insights
15.2 MARKET SIZE ESTIMATION
15.2.1 BOTTOM-UP APPROACH
15.2.2 TOP-DOWN APPROACH
15.2.3 BASE NUMBER ESTIMATION
15.3 MARKET FORECAST APPROACH
15.4 MARKET BREAKDOWN & DATA TRIANGULATION
15.5 RESEARCH ASSUMPTIONS
15.6 FACTOR ANALYSIS
15.7 RESEARCH LIMITATIONS
15.7.1 METHODOLOGY-RELATED LIMITATIONS
15.7.2 SCOPE-RELATED LIMITATIONS
15.8 RISK ASSESSMENT
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 OPPORTUNITIES FOR PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
3.2 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET,
BY END USER AND COUNTRY (2025)
3.3 PHYSIOTHERAPY EQUIPMENT MARKET: KEY COUNTRIES
3.4 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION (2026?2031)
3.5 PHYSIOTHERAPY EQUIPMENT MARKET: DEVELOPED VS. EMERGING MARKETS
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rapidly growing geriatric population and increasing incidence of chronic diseases
4.2.1.2 Growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular diseases
4.2.1.3 Rising demand for rehabilitation care
4.2.1.4 Growing demand for home-based and telerehabilitation care
4.2.2 RESTRAINTS
4.2.2.1 Unstable reimbursement scenario for physiotherapy
4.2.2.2 Direct access to physiotherapy
4.2.3 OPPORTUNITIES
4.2.3.1 Emerging markets
4.2.3.2 Rising technological advancements
4.2.4 CHALLENGES
4.2.4.1 Shortage of skilled personnel
4.2.4.2 Alternate therapies such as acupuncture
4.3 UNMET NEEDS & WHITE SPACES
4.3.1 UNMET NEEDS IN PHYSIOTHERAPY EQUIPMENT MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN REHABILITATION EQUIPMENT INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 ROLE IN ECOSYSTEM
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT,
BY PRODUCT, 2025
5.6.2 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT,
BY REGION, 2023–2025
5.7 TRADE ANALYSIS
5.7.1 IMPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019),
2021–2025
5.7.2 EXPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019),
2021–2025
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 CASE STUDY ANALYSIS
5.10.1 CASE STUDY 1: STARTOON LABS RECEIVED USFDA APPROVAL FOR PHEEZEE PHYSIOTHERAPY DEVICE
5.10.2 CASE STUDY 2: NHS IN THE UK TO LAUNCH AI-DRIVEN PHYSIOTHERAPY CLINIC
5.10.3 CASE STUDY 3: BURJEEL AND LEEJAM LAUNCH PHYSIOTHERABIA CENTERS IN RIYADH
5.11 INVESTMENT & FUNDING SCENARIO
5.12 IMPACT OF 2025 US TARIFFS ON PHYSIOTHERAPY EQUIPMENT MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON REGION
5.12.4.1 US
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.5 IMPACT ON END-USE INDUSTRIES
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS,
AND INNOVATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 AUGMENTED REALITY (AR)
6.3 TECHNOLOGY/PRODUCT ROADMAP
6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION
6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.4 PATENT ANALYSIS
6.4.1 PATENT PUBLICATION TRENDS FOR PHYSIOTHERAPY EQUIPMENT MARKET
6.4.2 TOP APPLICANTS (COMPANIES) OF PHYSIOTHERAPY EQUIPMENT PATENTS
6.4.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN PHYSIOTHERAPY EQUIPMENT MARKET
6.4.4 LIST OF MAJOR PATENTS
6.5 IMPACT OF AI/GEN AI ON PHYSIOTHERAPY EQUIPMENT MARKET
6.5.1 TOP USE CASES & MARKET POTENTIAL
6.5.2 TOP CASE STUDIES OF AI IMPLEMENTATION IN PHYSIOTHERAPY EQUIPMENT MARKET
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHYSIOTHERAPY EQUIPMENT MARKET
6.6 SUCCESS STORIES & REAL-WORLD APPLICATIONS
6.6.1 DIH MEDICAL/HOCOMA: LOKOMAT (ROBOT-ASSISTED GAIT REHABILITATION)
6.6.2 BTL INDUSTRIES: EMSELLA (NON-INVASIVE PELVIC FLOOR REHABILITATION)
6.6.3 STORZ MEDICAL: DUOLITH SD1 “ULTRA”(COMBINED SHOCKWAVE THERAPY IN SPORTS REHABILITATION)
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.1.2.1 North America
7.1.2.1.1 US
7.1.2.1.2 Canada
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.3.1 Japan
7.1.2.3.2 China
7.1.2.3.3 India
7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
7.2.1 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PHYSIOTHERAPY EQUIPMENT
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS IN END USERS
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 EQUIPMENT
9.2.1 ELECTROTHERAPY EQUIPMENT
9.2.1.1 Rising demand for non-pharmacological pain-management options to drive market growth
9.2.2 ULTRASOUND EQUIPMENT
9.2.2.1 High prevalence of musculoskeletal disorders and sports injuries and growing postoperative rehabilitation needs to boost growth
9.2.3 EXERCISE THERAPY EQUIPMENT
9.2.3.1 Shift toward active, function-oriented rehabilitation and growing emphasis on measurable clinical outcomes to fuel market growth
9.2.4 HEAT THERAPY EQUIPMENT
9.2.4.1 Expansion of outpatient rehabilitation and availability of portable products for supervised home use to drive growth
9.2.5 CRYOTHERAPY EQUIPMENT
9.2.5.1 Increasing orthopedic procedure volumes to support market growth
9.2.6 COMBINATION THERAPY EQUIPMENT
9.2.6.1 Ability of combination systems to consolidate capital purchases and improve clinical workflow to drive demand
9.2.7 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT
9.2.7.1 Ability to maintain passive joint mobility and reduce adverse effects of prolonged immobilization to fuel market
9.2.8 SHOCKWAVE THERAPY EQUIPMENT
9.2.8.1 Availability of compact radial systems suitable for physiotherapy and sports medicine clinics to boost demand
9.2.9 LASER THERAPY EQUIPMENT
9.2.9.1 Ability of higher-power systems to treat larger areas within shorter sessions to fuel growth
9.2.10 TRACTION THERAPY EQUIPMENT
9.2.10.1 Availability of programmable clinic-based and portable home-use devices to support growth
9.2.11 MAGNETIC PRESSURE THERAPY EQUIPMENT
9.2.11.1 Introduction of higher-intensity systems capable of stimulating deeper tissues without direct skin contact to drive adoption
9.2.12 OTHER PHYSIOTHERAPY EQUIPMENT
9.3 ACCESSORIES
9.3.1 PHYSIOTHERAPY FURNITURE
9.3.1.1 Growing use for physical therapy, rehab, occupational therapy, sports medicine, and chiropractic medicine to drive market
9.3.2 OTHER ACCESSORIES
10 PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 MUSCULOSKELETAL & ORTHOPEDIC REHABILITATION
10.2.1 RISING INCIDENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE DEMAND
10.3 NEUROLOGICAL REHABILITATION
10.3.1 SIGNIFICANT UNMET REHABILITATION NEEDS, PARTICULARLY IN EMERGING ECONOMIES, TO CREATE LONG-TERM MARKET OPPORTUNITY
10.4 CARDIOVASCULAR & PULMONARY REHABILITATION
10.4.1 GROWING CARDIOVASCULAR AND RESPIRATORY DISEASE BURDEN TO DRIVE DEMAND FOR EXERCISE THERAPY EQUIPMENT
10.5 SPORTS REHABILITATION
10.5.1 DEMAND FOR STRUCTURED REHABILITATION AND OBJECTIVE RETURN-TO-PLAY ASSESSMENTS TO BOOST MARKET
10.6 PELVIC HEALTH & UROGYNECOLOGICAL REHABILITATION
10.6.1 SHIFT TOWARD OUTPATIENT, HOME-BASED, AND REMOTELY MONITORED PELVIC-HEALTH PROGRAMS TO EXPAND ADDRESSABLE EQUIPMENT BASE
10.7 OTHER APPLICATIONS
11 PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER
11.1 INTRODUCTION
11.2 PHYSIOTHERAPY & REHABILITATION CENTERS
11.2.1 RISING INCIDENCE OF SPORTS INJURIES AND DISABILITIES TO DRIVE SEGMENT
11.3 HOSPITALS
11.3.1 GROWING PATIENT VOLUMES AT HOSPITALS TO DRIVE DEMAND
11.4 HOME CARE SETTINGS
11.4.1 RISING DEMAND FOR HOME CARE TO DRIVE DEMAND
11.5 PHYSICIANS’ OFFICES
11.5.1 COST-SAVING POTENTIAL AND QUALITY OF CARE PROVIDED IN PHYSICIANS’ OFFICES TO DRIVE GROWTH
11.6 OTHER END USERS
12 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 US
12.2.2.1 US to dominate North American market during forecast period
12.2.3 CANADA
12.2.3.1 Growing penetration of preventive care services to boost market
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 GERMANY
12.3.2.1 Rising geriatric population and increase in chronic conditions to drive demand
12.3.3 UK
12.3.3.1 Wide acceptance of physical therapy to increase adoption of physiotherapy equipment
12.3.4 FRANCE
12.3.4.1 Rising healthcare expenditure and favorable reimbursement scenario to drive market
12.3.5 ITALY
12.3.5.1 Increasing incidence of fall injuries and orthopedic disorders to drive market
12.3.6 SPAIN
12.3.6.1 Rising geriatric population to drive adoption of physiotherapy equipment
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 JAPAN
12.4.2.1 Large geriatric population to drive adoption of physiotherapy equipment
12.4.3 CHINA
12.4.3.1 Global manufacturing hub for physiotherapy and rehabilitation equipment to drive market
12.4.4 INDIA
12.4.4.1 Expansion of new acute care settings to drive demand
12.4.5 AUSTRALIA
12.4.5.1 Growing population and rising cases of chronic musculoskeletal conditions to drive market
12.4.6 SOUTH KOREA
12.4.6.1 Fast-growing aging population and rising medical tourism to drive market
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Rapidly aging population and expanding healthcare infrastructure to augment market growth
12.5.3 MEXICO
12.5.3.1 Advancements in healthcare infrastructure to drive market
12.5.4 ARGENTINA
12.5.4.1 Advancements in healthcare infrastructure to drive market
12.5.5 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 GCC COUNTRIES
12.6.2.1 Robust healthcare industry to drive market
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
13.3 REVENUE ANALYSIS, 2021–2025
13.4 MARKET RANKING ANALYSIS
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Product footprint
13.5.5.4 Application footprint
13.5.5.5 End-user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1 List of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 BRAND/PRODUCT COMPARISON
13.8 COMPANY VALUATION & FINANCIAL METRICS
13.8.1 FINANCIAL METRICS
13.8.2 COMPANY VALUATION
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & APPROVALS
13.9.2 DEALS
13.9.3 EXPANSIONS
13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION)
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches
14.1.1.3.2 Deals
14.1.1.3.3 Expansions
14.1.1.3.4 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 ZIMMER MEDIZINSYSTEME GMBH
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches
14.1.2.3.2 Deals
14.1.2.3.3 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.)
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches & approvals
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.3.4 Other developments
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS)
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches
14.1.4.3.2 Deals
14.1.4.3.3 Other developments
14.1.4.4 MnM view
14.1.4.4.1 Right to win
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses & competitive threats
14.1.5 ITO CO., LTD.
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 MnM view
14.1.5.3.1 Right to win
14.1.5.3.2 Strategic choices
14.1.5.3.3 Weaknesses & competitive threats
14.1.6 DYNATRONICS CORPORATION
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Product launches
14.1.6.3.2 Deals
14.1.6.3.3 Other developments
14.1.7 BTL INDUSTRIES
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.7.3.2 Deals
14.1.7.3.3 Expansions
14.1.7.3.4 Other developments
14.1.8 ENRAF-NONIUS B.V.
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Deals
14.1.9 MECTRONIC MEDICALE
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.10 RICHMAR (SUBSIDIARY OF DRIVE MEDICAL)
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches
14.1.10.3.2 Deals
14.1.11 STORZ MEDICAL AG
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.11.3 Recent developments
14.1.11.3.1 Product launches
14.1.11.3.2 Deals
14.1.11.3.3 Expansions
14.1.12 GYMNA INTERNATIONAL
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.12.3 Recent developments
14.1.12.3.1 Product launches
14.1.13 ASTAR
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.14 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED)
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 TACTILE MEDICAL
14.1.15.1 Business overview
14.1.15.2 Products offered
14.1.15.3 Recent developments
14.1.15.3.1 Product launches
14.1.16 DIH MEDICAL
14.1.16.1 Business overview
14.1.16.2 Products offered
14.1.16.3 Recent developments
14.1.16.3.1 Product launches
14.1.16.3.2 Deals
14.1.16.3.3 Other developments
14.1.17 TECHNOGYM SPA
14.1.17.1 Business overview
14.1.17.2 Products offered
14.1.17.3 Recent developments
14.1.17.3.1 Expansions
14.1.18 OMRON CORPORATION
14.1.18.1 Business overview
14.1.18.2 Products offered
14.1.19 OG WELLNESS TECHNOLOGIES CO., LTD.
14.1.19.1 Business overview
14.1.19.2 Products offered
14.1.19.3 Recent developments
14.1.19.3.1 Deals
14.1.20 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.
14.1.20.1 Business overview
14.1.20.2 Products offered
14.1.20.3 Recent developments
14.1.20.3.1 Product approvals & launches
14.2 OTHER PLAYERS
14.2.1 KINVENT
14.2.2 EXOATLET
14.2.3 MANAMED
14.2.4 BEABLE HEALTH PVT. LTD.
14.2.5 BALANCE METRIX
15 RESEARCH METHODOLOGY
15.1 RESEARCH APPROACH
15.1.1 SECONDARY DATA
15.1.1.1 Key data from secondary sources
15.1.2 PRIMARY DATA
15.1.2.1 Key data from primary sources
15.1.2.2 Key industry insights
15.2 MARKET SIZE ESTIMATION
15.2.1 BOTTOM-UP APPROACH
15.2.2 TOP-DOWN APPROACH
15.2.3 BASE NUMBER ESTIMATION
15.3 MARKET FORECAST APPROACH
15.4 MARKET BREAKDOWN & DATA TRIANGULATION
15.5 RESEARCH ASSUMPTIONS
15.6 FACTOR ANALYSIS
15.7 RESEARCH LIMITATIONS
15.7.1 METHODOLOGY-RELATED LIMITATIONS
15.7.2 SCOPE-RELATED LIMITATIONS
15.8 RISK ASSESSMENT
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 2 GROWTH RATE IN GERIATRIC POPULATION, BY REGION, 2020 VS. 2050
TABLE 3 PER CAPITA NATIONAL INCOME (USD)
TABLE 4 PHYSIOTHERAPY EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030
TABLE 6 PHYSIOTHERAPY EQUIPMENT MARKET: ROLE IN ECOSYSTEM
TABLE 7 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT, BY PRODUCT, 2025 (USD)
TABLE 8 AVERAGE SELLING PRICE OF ELECTROTHERAPY EQUIPMENT, BY REGION, 2023–2025 (USD)
TABLE 9 AVERAGE SELLING PRICE OF ULTRASOUND EQUIPMENT, BY REGION, 2023–2025 (USD)
TABLE 10 AVERAGE SELLING PRICE OF CRYOTHERAPY EQUIPMENT, BY REGION, 2023–2025 (USD)
TABLE 11 AVERAGE SELLING PRICE OF HEAT THERAPY EQUIPMENT, BY REGION, 2023–2025 (USD)
TABLE 12 IMPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 13 EXPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 14 PHYSIOTHERAPY EQUIPMENT MARKET: LIST OF KEY CONFERENCES & EVENTS, 2026–2027
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 16 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR PHYSIOTHERAPY EQUIPMENT
TABLE 17 PHYSIOTHERAPY EQUIPMENT MARKET: LIST OF MAJOR PATENTS
TABLE 18 TOP USE CASES & MARKET POTENTIAL
TABLE 19 PHYSIOTHERAPY EQUIPMENT MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
TABLE 20 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
TABLE 21 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 US: REGULATORY PROCESS FOR MEDICAL DEVICES
TABLE 23 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES
TABLE 24 CHINA: NATIONAL MEDICAL PRODUCTS ADMINISTRATION MEDICAL DEVICES CLASSIFICATION
TABLE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF END USERS
TABLE 26 KEY BUYING CRITERIA FOR END USERS
TABLE 27 ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 28 PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 29 PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 30 ELECTROTHERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 31 ELECTROTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32 ELECTROTHERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 33 ULTRASOUND EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 34 ULTRASOUND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 ULTRASOUND EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 36 EXERCISE THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 37 EXERCISE THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38 HEAT THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 39 HEAT THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40 HEAT THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 41 CRYOTHERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 42 CRYOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 CRYOTHERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 44 COMBINATION THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 45 COMBINATION THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 COMBINATION THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 47 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 48 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 50 SHOCKWAVE THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 51 SHOCKWAVE THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 SHOCKWAVE THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 53 LASER THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 54 LASER THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 LASER THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 56 TRACTION THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 57 TRACTION THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58 TRACTION THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 59 MAGNETIC PRESSURE THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 60 MAGNETIC PRESSURE THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 MAGNETIC PRESSURE THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 62 OTHER PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 64 PHYSIOTHERAPY ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 PHYSIOTHERAPY FURNITURE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66 OTHER ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 68 PHYSIOTHERAPY EQUIPMENT MARKET FOR MUSCULOSKELETAL & ORTHOPEDIC REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 PHYSIOTHERAPY EQUIPMENT MARKET FOR NEUROLOGICAL REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 PHYSIOTHERAPY EQUIPMENT MARKET FOR CARDIOVASCULAR & PULMONARY REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71 PHYSIOTHERAPY EQUIPMENT MARKET FOR SPORTS REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 PHYSIOTHERAPY EQUIPMENT MARKET FOR PELVIC HEALTH & UROGYNECOLOGICAL REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73 PHYSIOTHERAPY EQUIPMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74 PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 75 PHYSIOTHERAPY EQUIPMENT MARKET FOR PHYSIOTHERAPY & REHABILITATION CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 PHYSIOTHERAPY EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 PHYSIOTHERAPY EQUIPMENT MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78 PHYSIOTHERAPY EQUIPMENT MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 PHYSIOTHERAPY EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 81 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 83 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 84 NORTH AMERICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 85 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 86 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 87 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 88 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 89 US: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 90 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 91 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER,
024–2031 (USD MILLION)
TABLE 92 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 93 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 94 CANADA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 96 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 97 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 99 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 100 EUROPE: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 102 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 103 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 104 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105 GERMANY: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 106 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 107 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 108 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 109 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110 UK: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 112 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 113 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 114 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115 FRANCE: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 117 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 118 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 119 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120 ITALY: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 121 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 122 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 123 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 124 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125 SPAIN: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 127 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 128 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 129 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130 REST OF EUROPE: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 132 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 133 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 135 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136 ASIA PACIFIC: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 137 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 138 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 139 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 140 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141 JAPAN: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 142 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 143 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 144 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 145 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146 CHINA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 148 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 149 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 150 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151 INDIA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 152 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 153 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 154 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 155 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156 AUSTRALIA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 158 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 159 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 160 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161 SOUTH KOREA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 162 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 163 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 164 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 165 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166 REST OF ASIA PACIFIC: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 168 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 169 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 170 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 171 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 172 LATIN AMERICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 173 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 174 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 175 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 176 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177 BRAZIL: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 178 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 179 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 180 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 181 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 182 MEXICO: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 184 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 185 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 186 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 ARGENTINA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 188 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 189 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 190 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 191 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192 REST OF LATIN AMERICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 194 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 195 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 197 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 MIDDLE EAST & AFRICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 200 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 201 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 202 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203 GCC COUNTRIES: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 204 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 205 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 206 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 207 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 210 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 211 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
TABLE 212 PHYSIOTHERAPY EQUIPMENT MARKET: REGION FOOTPRINT
TABLE 213 PHYSIOTHERAPY EQUIPMENT MARKET: PRODUCT FOOTPRINT
TABLE 214 PHYSIOTHERAPY EQUIPMENT MARKET: APPLICATION FOOTPRINT
TABLE 215 PHYSIOTHERAPY EQUIPMENT MARKET: END-USER FOOTPRINT
TABLE 216 PHYSIOTHERAPY EQUIPMENT MARKET: LIST OF KEY STARTUPS/SMES
TABLE 217 PHYSIOTHERAPY EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 218 PHYSIOTHERAPY EQUIPMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JULY 2022–JUNE 2026
TABLE 219 PHYSIOTHERAPY EQUIPMENT MARKET: DEALS, JULY 2022–JUNE 2026
TABLE 220 PHYSIOTHERAPY EQUIPMENT MARKET: EXPANSIONS, JULY 2022–JUNE 2026
TABLE 221 PHYSIOTHERAPY EQUIPMENT MARKET: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 222 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): COMPANY OVERVIEW
TABLE 223 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): PRODUCTS OFFERED
TABLE 224 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 225 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): DEALS, JULY 2022–JUNE 2026
TABLE 226 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): EXPANSIONS, JULY 2022– JUNE 2026
TABLE 227 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): OTHER DEVELOPMENTS, JULY 2022– JUNE 2026
TABLE 228 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW
TABLE 229 ZIMMER MEDIZINSYSTEME GMBH: PRODUCTS OFFERED
TABLE 230 ZIMMER MEDIZINSYSTEME GMBH: PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 231 ZIMMER MEDIZINSYSTEME GMBH: DEALS, JULY 2022–JUNE 2026
TABLE 232 ZIMMER MEDIZINSYSTEME GMBH: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 233 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): COMPANY OVERVIEW
TABLE 234 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): PRODUCTS OFFERED
TABLE 235 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): PRODUCT LAUNCHES & APPROVALS, JULY 2022–JUNE 2026
TABLE 236 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): DEALS, JULY 2022–JUNE 2026
TABLE 237 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): EXPANSIONS, JULY 2022–JUNE 2026
TABLE 238 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 239 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): COMPANY OVERVIEW
TABLE 240 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): PRODUCTS OFFERED
TABLE 241 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 242 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): DEALS, JULY 2022–JUNE 2026
TABLE 243 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 244 ITO CO., LTD.: COMPANY OVERVIEW
TABLE 245 ITO CO., LTD.: PRODUCTS OFFERED
TABLE 246 DYNATRONICS CORPORATION: COMPANY OVERVIEW
TABLE 247 DYNATRONICS CORPORATION: PRODUCTS OFFERED
TABLE 248 DYNATRONICS CORPORATION: PRODUCT LAUNCHES, APRIL 2022–JUNE 2026
TABLE 249 DYNATRONICS CORPORATION: DEALS, JULY 2022–JUNE 2026
TABLE 250 DYNATRONICS CORPORATION: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 251 BTL INDUSTRIES: COMPANY OVERVIEW
TABLE 252 BTL INDUSTRIES: PRODUCTS OFFERED
TABLE 253 BTL INDUSTRIES: PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 254 BTL INDUSTRIES: DEALS, JULY 2022–JUNE 2026
TABLE 255 BTL INDUSTRIES: EXPANSIONS, JULY 2022–JUNE 2026
TABLE 256 BTL INDUSTRIES: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 257 ENRAF-NONIUS B.V.: COMPANY OVERVIEW
TABLE 258 ENRAF-NONIUS B.V.: PRODUCTS OFFERED
TABLE 259 ENRAF-NONIUS B.V.: DEALS, JULY 2022–JUNE 2026
TABLE 260 MECTRONIC MEDICALE: COMPANY OVERVIEW
TABLE 261 MECTRONIC MEDICALE: PRODUCTS OFFERED
TABLE 262 RICHMAR: COMPANY OVERVIEW
TABLE 263 RICHMAR: PRODUCTS OFFERED
TABLE 264 RICHMAR: PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 265 RICHMAR: DEALS, JULY 2022–JUNE 2026
TABLE 266 STORZ MEDICAL AG: COMPANY OVERVIEW
TABLE 267 STORZ MEDICAL AG: PRODUCTS OFFERED
TABLE 268 STORZ MEDICAL AG: PRODUCT LAUNCHES, JULY 2022–SEPTEMBER 2024
TABLE 269 STORZ MEDICAL AG: DEALS, JULY 2022–SEPTEMBER 2024
TABLE 270 STORZ MEDICAL AG: EXPANSIONS, JULY 2022–SEPTEMBER 2024
TABLE 271 GYMNA INTERNATIONAL: COMPANY OVERVIEW
TABLE 272 GYMNA INTERNATIONAL: PRODUCTS OFFERED
TABLE 273 GYMNA INTERNATIONAL: PRODUCT LAUNCHES, JULY 2022–SEPTEMBER 2024
TABLE 274 ASTAR: COMPANY OVERVIEW
TABLE 275 ASTAR: PRODUCTS OFFERED
TABLE 276 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED): COMPANY OVERVIEW
TABLE 277 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED): PRODUCTS OFFERED
TABLE 278 TACTILE MEDICAL: COMPANY OVERVIEW
TABLE 279 TACTILE MEDICAL: PRODUCTS OFFERED
TABLE 280 TACTILE MEDICAL: PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 281 DIH MEDICAL: COMPANY OVERVIEW
TABLE 282 DIH MEDICAL: PRODUCTS OFFERED
TABLE 283 DIH MEDICAL: PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 284 DIH MEDICAL: DEALS, JULY 2022–JUNE 2026
TABLE 285 DIH MEDICAL: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 286 TECHNOGYM SPA: COMPANY OVERVIEW
TABLE 287 TECHNOGYM SPA: PRODUCTS OFFERED
TABLE 288 TECHNOGYM SPA: EXPANSIONS, JULY 2022–JUNE 2026
TABLE 289 OMRON CORPORATION: COMPANY OVERVIEW
TABLE 290 OMRON CORPORATION: PRODUCTS OFFERED
TABLE 291 OG WELLNESS TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
TABLE 292 OG WELLNESS TECHNOLOGIES CO., LTD.: PRODUCTS OFFERED
TABLE 293 OG WELLNESS TECHNOLOGIES CO., LTD.: DEALS, JULY 2022–JUNE 2026
TABLE 294 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 295 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
TABLE 296 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.: PRODUCT APPROVALS & LAUNCHES, JULY 2022–JUNE 2026
TABLE 297 RISK ASSESSMENT: PHYSIOTHERAPY EQUIPMENT MARKET
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 2 GROWTH RATE IN GERIATRIC POPULATION, BY REGION, 2020 VS. 2050
TABLE 3 PER CAPITA NATIONAL INCOME (USD)
TABLE 4 PHYSIOTHERAPY EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030
TABLE 6 PHYSIOTHERAPY EQUIPMENT MARKET: ROLE IN ECOSYSTEM
TABLE 7 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT, BY PRODUCT, 2025 (USD)
TABLE 8 AVERAGE SELLING PRICE OF ELECTROTHERAPY EQUIPMENT, BY REGION, 2023–2025 (USD)
TABLE 9 AVERAGE SELLING PRICE OF ULTRASOUND EQUIPMENT, BY REGION, 2023–2025 (USD)
TABLE 10 AVERAGE SELLING PRICE OF CRYOTHERAPY EQUIPMENT, BY REGION, 2023–2025 (USD)
TABLE 11 AVERAGE SELLING PRICE OF HEAT THERAPY EQUIPMENT, BY REGION, 2023–2025 (USD)
TABLE 12 IMPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 13 EXPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 14 PHYSIOTHERAPY EQUIPMENT MARKET: LIST OF KEY CONFERENCES & EVENTS, 2026–2027
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 16 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR PHYSIOTHERAPY EQUIPMENT
TABLE 17 PHYSIOTHERAPY EQUIPMENT MARKET: LIST OF MAJOR PATENTS
TABLE 18 TOP USE CASES & MARKET POTENTIAL
TABLE 19 PHYSIOTHERAPY EQUIPMENT MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
TABLE 20 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
TABLE 21 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 US: REGULATORY PROCESS FOR MEDICAL DEVICES
TABLE 23 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES
TABLE 24 CHINA: NATIONAL MEDICAL PRODUCTS ADMINISTRATION MEDICAL DEVICES CLASSIFICATION
TABLE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF END USERS
TABLE 26 KEY BUYING CRITERIA FOR END USERS
TABLE 27 ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 28 PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 29 PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 30 ELECTROTHERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 31 ELECTROTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32 ELECTROTHERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 33 ULTRASOUND EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 34 ULTRASOUND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 ULTRASOUND EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 36 EXERCISE THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 37 EXERCISE THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38 HEAT THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 39 HEAT THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40 HEAT THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 41 CRYOTHERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 42 CRYOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 CRYOTHERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 44 COMBINATION THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 45 COMBINATION THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 COMBINATION THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 47 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 48 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 50 SHOCKWAVE THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 51 SHOCKWAVE THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 SHOCKWAVE THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 53 LASER THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 54 LASER THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 LASER THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 56 TRACTION THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 57 TRACTION THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58 TRACTION THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 59 MAGNETIC PRESSURE THERAPY EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 60 MAGNETIC PRESSURE THERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 MAGNETIC PRESSURE THERAPY EQUIPMENT MARKET, 2024–2031 (UNIT THOUSANDS)
TABLE 62 OTHER PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 64 PHYSIOTHERAPY ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 PHYSIOTHERAPY FURNITURE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66 OTHER ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 68 PHYSIOTHERAPY EQUIPMENT MARKET FOR MUSCULOSKELETAL & ORTHOPEDIC REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 PHYSIOTHERAPY EQUIPMENT MARKET FOR NEUROLOGICAL REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 PHYSIOTHERAPY EQUIPMENT MARKET FOR CARDIOVASCULAR & PULMONARY REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71 PHYSIOTHERAPY EQUIPMENT MARKET FOR SPORTS REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 PHYSIOTHERAPY EQUIPMENT MARKET FOR PELVIC HEALTH & UROGYNECOLOGICAL REHABILITATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73 PHYSIOTHERAPY EQUIPMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74 PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 75 PHYSIOTHERAPY EQUIPMENT MARKET FOR PHYSIOTHERAPY & REHABILITATION CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 PHYSIOTHERAPY EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 PHYSIOTHERAPY EQUIPMENT MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78 PHYSIOTHERAPY EQUIPMENT MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 PHYSIOTHERAPY EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 81 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 83 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 84 NORTH AMERICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 85 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 86 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 87 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 88 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 89 US: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 90 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 91 US: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER,
024–2031 (USD MILLION)
TABLE 92 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 93 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 94 CANADA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 96 CANADA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 97 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 99 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 100 EUROPE: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 102 EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 103 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 104 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105 GERMANY: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 106 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 107 GERMANY: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 108 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 109 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110 UK: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 112 UK: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 113 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 114 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115 FRANCE: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 117 FRANCE: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 118 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 119 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120 ITALY: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 121 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 122 ITALY: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 123 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 124 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125 SPAIN: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 127 SPAIN: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 128 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 129 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130 REST OF EUROPE: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 132 REST OF EUROPE: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 133 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 135 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136 ASIA PACIFIC: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 137 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 138 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 139 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 140 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141 JAPAN: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 142 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 143 JAPAN: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 144 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 145 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146 CHINA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 148 CHINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 149 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 150 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151 INDIA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 152 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 153 INDIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 154 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 155 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156 AUSTRALIA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 158 AUSTRALIA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 159 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 160 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161 SOUTH KOREA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 162 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 163 SOUTH KOREA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 164 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 165 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166 REST OF ASIA PACIFIC: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 168 REST OF ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 169 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 170 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 171 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 172 LATIN AMERICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 173 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 174 LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 175 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 176 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177 BRAZIL: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 178 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 179 BRAZIL: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 180 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 181 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 182 MEXICO: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 184 MEXICO: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 185 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 186 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 ARGENTINA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 188 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 189 ARGENTINA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 190 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 191 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192 REST OF LATIN AMERICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 194 REST OF LATIN AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 195 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 197 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 MIDDLE EAST & AFRICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 200 MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 201 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 202 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203 GCC COUNTRIES: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 204 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 205 GCC COUNTRIES: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 206 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 207 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY ACCESSORIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 210 REST OF MIDDLE EAST & AFRICA: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 211 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
TABLE 212 PHYSIOTHERAPY EQUIPMENT MARKET: REGION FOOTPRINT
TABLE 213 PHYSIOTHERAPY EQUIPMENT MARKET: PRODUCT FOOTPRINT
TABLE 214 PHYSIOTHERAPY EQUIPMENT MARKET: APPLICATION FOOTPRINT
TABLE 215 PHYSIOTHERAPY EQUIPMENT MARKET: END-USER FOOTPRINT
TABLE 216 PHYSIOTHERAPY EQUIPMENT MARKET: LIST OF KEY STARTUPS/SMES
TABLE 217 PHYSIOTHERAPY EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 218 PHYSIOTHERAPY EQUIPMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JULY 2022–JUNE 2026
TABLE 219 PHYSIOTHERAPY EQUIPMENT MARKET: DEALS, JULY 2022–JUNE 2026
TABLE 220 PHYSIOTHERAPY EQUIPMENT MARKET: EXPANSIONS, JULY 2022–JUNE 2026
TABLE 221 PHYSIOTHERAPY EQUIPMENT MARKET: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 222 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): COMPANY OVERVIEW
TABLE 223 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): PRODUCTS OFFERED
TABLE 224 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 225 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): DEALS, JULY 2022–JUNE 2026
TABLE 226 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): EXPANSIONS, JULY 2022– JUNE 2026
TABLE 227 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): OTHER DEVELOPMENTS, JULY 2022– JUNE 2026
TABLE 228 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW
TABLE 229 ZIMMER MEDIZINSYSTEME GMBH: PRODUCTS OFFERED
TABLE 230 ZIMMER MEDIZINSYSTEME GMBH: PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 231 ZIMMER MEDIZINSYSTEME GMBH: DEALS, JULY 2022–JUNE 2026
TABLE 232 ZIMMER MEDIZINSYSTEME GMBH: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 233 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): COMPANY OVERVIEW
TABLE 234 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): PRODUCTS OFFERED
TABLE 235 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): PRODUCT LAUNCHES & APPROVALS, JULY 2022–JUNE 2026
TABLE 236 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): DEALS, JULY 2022–JUNE 2026
TABLE 237 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): EXPANSIONS, JULY 2022–JUNE 2026
TABLE 238 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.): OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 239 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): COMPANY OVERVIEW
TABLE 240 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): PRODUCTS OFFERED
TABLE 241 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 242 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): DEALS, JULY 2022–JUNE 2026
TABLE 243 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS): OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 244 ITO CO., LTD.: COMPANY OVERVIEW
TABLE 245 ITO CO., LTD.: PRODUCTS OFFERED
TABLE 246 DYNATRONICS CORPORATION: COMPANY OVERVIEW
TABLE 247 DYNATRONICS CORPORATION: PRODUCTS OFFERED
TABLE 248 DYNATRONICS CORPORATION: PRODUCT LAUNCHES, APRIL 2022–JUNE 2026
TABLE 249 DYNATRONICS CORPORATION: DEALS, JULY 2022–JUNE 2026
TABLE 250 DYNATRONICS CORPORATION: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 251 BTL INDUSTRIES: COMPANY OVERVIEW
TABLE 252 BTL INDUSTRIES: PRODUCTS OFFERED
TABLE 253 BTL INDUSTRIES: PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 254 BTL INDUSTRIES: DEALS, JULY 2022–JUNE 2026
TABLE 255 BTL INDUSTRIES: EXPANSIONS, JULY 2022–JUNE 2026
TABLE 256 BTL INDUSTRIES: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 257 ENRAF-NONIUS B.V.: COMPANY OVERVIEW
TABLE 258 ENRAF-NONIUS B.V.: PRODUCTS OFFERED
TABLE 259 ENRAF-NONIUS B.V.: DEALS, JULY 2022–JUNE 2026
TABLE 260 MECTRONIC MEDICALE: COMPANY OVERVIEW
TABLE 261 MECTRONIC MEDICALE: PRODUCTS OFFERED
TABLE 262 RICHMAR: COMPANY OVERVIEW
TABLE 263 RICHMAR: PRODUCTS OFFERED
TABLE 264 RICHMAR: PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 265 RICHMAR: DEALS, JULY 2022–JUNE 2026
TABLE 266 STORZ MEDICAL AG: COMPANY OVERVIEW
TABLE 267 STORZ MEDICAL AG: PRODUCTS OFFERED
TABLE 268 STORZ MEDICAL AG: PRODUCT LAUNCHES, JULY 2022–SEPTEMBER 2024
TABLE 269 STORZ MEDICAL AG: DEALS, JULY 2022–SEPTEMBER 2024
TABLE 270 STORZ MEDICAL AG: EXPANSIONS, JULY 2022–SEPTEMBER 2024
TABLE 271 GYMNA INTERNATIONAL: COMPANY OVERVIEW
TABLE 272 GYMNA INTERNATIONAL: PRODUCTS OFFERED
TABLE 273 GYMNA INTERNATIONAL: PRODUCT LAUNCHES, JULY 2022–SEPTEMBER 2024
TABLE 274 ASTAR: COMPANY OVERVIEW
TABLE 275 ASTAR: PRODUCTS OFFERED
TABLE 276 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED): COMPANY OVERVIEW
TABLE 277 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED): PRODUCTS OFFERED
TABLE 278 TACTILE MEDICAL: COMPANY OVERVIEW
TABLE 279 TACTILE MEDICAL: PRODUCTS OFFERED
TABLE 280 TACTILE MEDICAL: PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 281 DIH MEDICAL: COMPANY OVERVIEW
TABLE 282 DIH MEDICAL: PRODUCTS OFFERED
TABLE 283 DIH MEDICAL: PRODUCT LAUNCHES, JULY 2022–JUNE 2026
TABLE 284 DIH MEDICAL: DEALS, JULY 2022–JUNE 2026
TABLE 285 DIH MEDICAL: OTHER DEVELOPMENTS, JULY 2022–JUNE 2026
TABLE 286 TECHNOGYM SPA: COMPANY OVERVIEW
TABLE 287 TECHNOGYM SPA: PRODUCTS OFFERED
TABLE 288 TECHNOGYM SPA: EXPANSIONS, JULY 2022–JUNE 2026
TABLE 289 OMRON CORPORATION: COMPANY OVERVIEW
TABLE 290 OMRON CORPORATION: PRODUCTS OFFERED
TABLE 291 OG WELLNESS TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
TABLE 292 OG WELLNESS TECHNOLOGIES CO., LTD.: PRODUCTS OFFERED
TABLE 293 OG WELLNESS TECHNOLOGIES CO., LTD.: DEALS, JULY 2022–JUNE 2026
TABLE 294 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 295 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
TABLE 296 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.: PRODUCT APPROVALS & LAUNCHES, JULY 2022–JUNE 2026
TABLE 297 RISK ASSESSMENT: PHYSIOTHERAPY EQUIPMENT MARKET
LIST OF FIGURES
FIGURE 1 PHYSIOTHERAPY EQUIPMENT MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 3 PHYSIOTHERAPY EQUIPMENT MARKET, 2024–2031 (USD MILLION)
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PHYSIOTHERAPY EQUIPMENT MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN PHYSIOTHERAPY EQUIPMENT MARKET, 2025
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 8 RISING GERIATRIC POPULATION AND INCREASING CHRONIC DISEASES TO DRIVE MARKET
FIGURE 9 PHYSIOTHERAPY & REHABILITATION CENTERS AND JAPAN ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 10 CHINA TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
FIGURE 11 EUROPE TO DOMINATE MARKET IN 2031
FIGURE 12 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 13 PHYSIOTHERAPY EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 PHYSIOTHERAPY EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15 PHYSIOTHERAPY EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 16 PHYSIOTHERAPY EQUIPMENT MARKET: VALUE CHAIN ANALYSIS
FIGURE 17 PHYSIOTHERAPY EQUIPMENT MARKET: ECOSYSTEM ANALYSIS
FIGURE 18 PHYSIOTHERAPY EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 19 INVESTMENT/VENTURE CAPITAL SCENARIO IN PHYSIOTHERAPY EQUIPMENT MARKET, 2022–2025
FIGURE 20 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) IN PHYSIOTHERAPY EQUIPMENT (JANUARY 2015–DECEMBER 2025)
FIGURE 21 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PHYSIOTHERAPY EQUIPMENT PATENTS, 2015–2025
FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PHYSIOTHERAPY PRODUCT END USERS
FIGURE 23 KEY BUYING CRITERIA FOR END USERS
FIGURE 24 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
FIGURE 25 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET SNAPSHOT
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET (2021–2025)
FIGURE 28 PHYSIOTHERAPY EQUIPMENT MARKET RANKING, BY KEY PLAYERS (2025)
FIGURE 29 PHYSIOTHERAPY EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 30 PHYSIOTHERAPY EQUIPMENT MARKET: COMPANY FOOTPRINT
FIGURE 31 PHYSIOTHERAPY EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 32 PHYSIOTHERAPY EQUIPMENT MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 33 EV/EBITDA OF KEY VENDORS
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 35 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): COMPANY SNAPSHOT (2025)
FIGURE 36 ZYNEX, INC.: COMPANY SNAPSHOT (2024)
FIGURE 37 DYNATRONICS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 38 TACTILE MEDICAL: COMPANY SNAPSHOT (2025)
FIGURE 39 DIH MEDICAL: COMPANY SNAPSHOT (2024)
FIGURE 40 TECHNOGYM SPA: COMPANY SNAPSHOT (2025)
FIGURE 41 OMRON CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 42 RESEARCH DESIGN
FIGURE 43 PRIMARY SOURCES
FIGURE 44 BOTTOM-UP APPROACH
FIGURE 45 TOP-DOWN APPROACH
FIGURE 46 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 47 MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS
FIGURE 48 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 49 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 1 PHYSIOTHERAPY EQUIPMENT MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 3 PHYSIOTHERAPY EQUIPMENT MARKET, 2024–2031 (USD MILLION)
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PHYSIOTHERAPY EQUIPMENT MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN PHYSIOTHERAPY EQUIPMENT MARKET, 2025
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 8 RISING GERIATRIC POPULATION AND INCREASING CHRONIC DISEASES TO DRIVE MARKET
FIGURE 9 PHYSIOTHERAPY & REHABILITATION CENTERS AND JAPAN ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 10 CHINA TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
FIGURE 11 EUROPE TO DOMINATE MARKET IN 2031
FIGURE 12 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 13 PHYSIOTHERAPY EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 PHYSIOTHERAPY EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15 PHYSIOTHERAPY EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 16 PHYSIOTHERAPY EQUIPMENT MARKET: VALUE CHAIN ANALYSIS
FIGURE 17 PHYSIOTHERAPY EQUIPMENT MARKET: ECOSYSTEM ANALYSIS
FIGURE 18 PHYSIOTHERAPY EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 19 INVESTMENT/VENTURE CAPITAL SCENARIO IN PHYSIOTHERAPY EQUIPMENT MARKET, 2022–2025
FIGURE 20 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) IN PHYSIOTHERAPY EQUIPMENT (JANUARY 2015–DECEMBER 2025)
FIGURE 21 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PHYSIOTHERAPY EQUIPMENT PATENTS, 2015–2025
FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PHYSIOTHERAPY PRODUCT END USERS
FIGURE 23 KEY BUYING CRITERIA FOR END USERS
FIGURE 24 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
FIGURE 25 NORTH AMERICA: PHYSIOTHERAPY EQUIPMENT MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET SNAPSHOT
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET (2021–2025)
FIGURE 28 PHYSIOTHERAPY EQUIPMENT MARKET RANKING, BY KEY PLAYERS (2025)
FIGURE 29 PHYSIOTHERAPY EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 30 PHYSIOTHERAPY EQUIPMENT MARKET: COMPANY FOOTPRINT
FIGURE 31 PHYSIOTHERAPY EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 32 PHYSIOTHERAPY EQUIPMENT MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 33 EV/EBITDA OF KEY VENDORS
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 35 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION): COMPANY SNAPSHOT (2025)
FIGURE 36 ZYNEX, INC.: COMPANY SNAPSHOT (2024)
FIGURE 37 DYNATRONICS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 38 TACTILE MEDICAL: COMPANY SNAPSHOT (2025)
FIGURE 39 DIH MEDICAL: COMPANY SNAPSHOT (2024)
FIGURE 40 TECHNOGYM SPA: COMPANY SNAPSHOT (2025)
FIGURE 41 OMRON CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 42 RESEARCH DESIGN
FIGURE 43 PRIMARY SOURCES
FIGURE 44 BOTTOM-UP APPROACH
FIGURE 45 TOP-DOWN APPROACH
FIGURE 46 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 47 MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS
FIGURE 48 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 49 MARKET DATA TRIANGULATION METHODOLOGY
